Latest News from Children’s Brain Tumor Foundation
NEW CLUES TOWARD TREATING PEDIATRIC BRAIN TUMORS HARBORING EPIGENETIC MUTATION
While substantial strides have been made against some types of childhood cancers, high-grade gliomas still lack effective treatments. Thirty to 60% of these pediatric brain tumors bear mutations in the gene H3F3A. This gene contains the encoded blueprint for histone...
MOTHER/DAUGHTER NURSE PRACTITIONERS GUIDE CHILDREN THROUGH CANCER TREATMENT, SURVIVORSHIP
CBTF is proud to collaborate with Memorial Sloan Kettering Cancer Center and thank them for the amazing neuro-oncology work they do in their Long-Term Survivor Clinic, where they dedicate time and resources specifically for brain tumor survivors. Mother/daughter nurse...
CHILDREN’S CANCER CAUSE PRESENTS ROSEN RESEARCH AWARD TO CONGRESSWOMAN JACKIE SPEIER
WASHINGTON, DC, USA, November 4, 2021 /EINPresswire.com/ -- Children’s Cancer Cause is honored to announce that Representative Jackie Speier (CA-14) is the recipient of the 2021 Leonard M. Rosen Memorial Research Award, presented annually to an individual who has made...
CHILDREN’S BRAIN TUMOR NETWORK RECEIVES CRITICAL GOVERNMENT SUPPORT FOR GENETIC RESEARCH OF CHILDHOOD TUMORS
PHILADELPHIA, PA - Tuesday, Nov. 2, 2021 Unlocking the genetic mysteries behind pediatric brain tumors to accelerate the research process is at the heart of the mission of the Children’s Brain Tumor Network (CBTN). CBTN, a multi-institutional brain tumor research...
PRESS RELEASE: Teen Brain Tumor Survivors Supporting Newly Diagnosed Teens
UNITED STATES OF AMERICA, September 15, 2021 /EINPresswire.com/ -- Children's Brain Tumor Foundation (CBTF) is excited to announce the rollout of their Teen Care Kit program. When a teen is diagnosed with a brain tumor, they often feel alone and have a multitude of...
PRESS RELEASE: CHILDREN’S BRAIN TUMOR FOUNDATION ANNOUNCES NEW SURVIVOR STRONG SCHOLARSHIP
EIN Presswire - NEW YORK, NEW YORK, UNITED STATES, October 12, 2021 Children's Brain Tumor Foundation is excited to announce their newest scholarship, Survivor Strong. This $2500 scholarship is sponsored by Allan and Phyllis Walters, who believe in the strength and...
A DISCUSSION WITH DR. ANNAH ABRAMS OF MASSACHUSETTS GENERAL HOSPITAL
DECODING THE BIOLOGY OF OLIGODENDROGLIOMA THROUGH A NEW MODEL FOR COLLABORATION
-Jonathon Waller, Children's Brain Tumor Network Brain and spinal cord tumors are the second most common cancers in children (after leukemia) and the leading cause of disease-related death in children in the US. They account for about 1 out of 4 childhood cancers....
ISRAEL PRINTS WORLD’S FIRST 3D LIVING MALIGNANT BRAIN TUMOR
The Jerusalem Post - A team of Israeli researchers from Tel Aviv University has printed the world’s first viable malignant brain tumor using a 3D printer, recreating the flowing blood vessels and surrounding brain tissue. The glioblastoma tumor is based on samples...
PEDIATRIC BRAIN RESEARCH PUSHED FORWARD WITH DAYTON LIVING TUMOR BANK
The Children's Brain Tumor Foundation is a proud founding member of the Children's Brain Tumor Network (formally CBTTC). We are also privileged to have Dr. Lober as a key member of our board of directors. Dayton Daily News - When brain tumors were removed from kids at...
FINDING AN UNEXPECTED CALLING: 8 Questions with Child Neurologist Yasmin Khakoo
This is a wonderful piece on our friend and associate at Memorial Sloan Kettering Cancer Center, Pediatric Neurologist & Neuro-Oncologist, Yasmin Khakoo. We are thankful to have such a dedicated and caring member in our community; thanks for all that you do...
Simple urine test may help early detection of brain tumors
A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings, published in the journal ACS Applied Materials & Interfaces, have indicated that regular urine tests could...
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models
As we all know, there continues to be a dire need for new treatment options for diffuse midline gliomas #DMG A breakthrough in recent years have shown that many DMGs have a specific K27M mutation on Histone protein H3. What are histones? Histones bind, unwrap or...
COMBINATION OF DRUGS PROMISING FOR BRAIN TUMOR TREATMENTS
- Chia-Yi, Hou Changing America Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours to the...
IMMUNOCOMPROMISED AND CONCERNED ABOUT THE VACCINE? HERE’S WHAT YOU NEED TO KNOW
-MORNING EDITION, NPR NEWS Lots of people have questions about getting vaccinated against COVID-19. That includes the millions of Americans with weakened immune systems that put them at higher risk of severe disease if they do get infected with the coronavirus....